(Q34036984)

30 July 2017

1 reference

title

Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormone deficiency and osteoporosis (English)

1 reference

growth hormone deficiency

30 July 2017

0 references

1 reference

Wüster C

1

1 reference

30 July 2017

Härle U

2

1 reference

30 July 2017

Rehn U

3

1 reference

30 July 2017

Müller C

4

1 reference

30 July 2017

Knauf K

5

1 reference

30 July 2017

Köppler D

6

1 reference

30 July 2017

Schwabe C

7

1 reference

30 July 2017

Ziegler R

8

1 reference

30 July 2017

publication date

1 February 1998

1 reference

Growth Hormone & I G F Research

30 July 2017

published in

1 reference

30 July 2017

volume

8 Suppl A

1 reference

30 July 2017

page(s)

87-94

1 reference

Mechanical properties and biochemical composition of rat cortical femur and tibia after long-term treatment with biosynthetic human growth hormone

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone is not able to counteract osteopenia of rat cortical bone induced by glucocorticoid with protracted effect.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Bone mineral status in growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Bone mass of spine and forearm in osteoporosis and in German normals: influences of sex, age and anthropometric parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Increased prevalence of osteoporosis and arteriosclerosis in conventionally substituted anterior pituitary insufficiency: need for additional growth hormone substitution?

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone deficiency during puberty reduces adult bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Reduced bone mineral content in adult patients with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Low bone mineral density in adults with previous hypothalamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Consequences of childhood-onset growth hormone deficiency for adult bone mass

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Elderly patients with adult-onset growth hormone deficiency are not osteopenic.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Serum bone GLA-protein in growth hormone deficient children

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

GH and bone metabolism: the role of the vitamin D system

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of short term administration of recombinant human growth hormone to elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of human growth hormone in men over 60 years old

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of Human Growth Hormone on Body Composition in Elderly Men

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Human growth hormone and growth hormone releasing hormone: a double-masked, placebo-controlled study of their effects on bone metabolism in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of sex and age on growth hormone response to growth hormone-releasing hormone in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of growth hormone (GH) replacement on bone metabolism and mineral density in adult onset of GH deficiency: results of a double-blind placebo-controlled study with open follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Low plasma levels of insulin-like growth factor 1 (IGF-1) in male patients with idiopathic osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Effects of growth hormone in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Treatment of osteoporosis with calcitonin, with and without growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Coherence treatment of postmenopausal osteoporosis with growth hormone and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Insulinlike growth factors: Potential therapeutic options for osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone, insulin-like growth factor I, and bone: a clinical review

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Growth hormone and adult bone remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: a placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1096-6374%2898%2980016-6

7 January 2021

10.1016/S1096-6374(98)80016-6

Identifiers

DOI

1 reference

30 July 2017

1 reference